Keating Financial Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Keating Financial Advisory Services's PFE Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Pfizer (PFE) stake by 18% in Q2 2026, buying an estimated $18.2K and bringing the position to 4,601 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #464.
Keating Financial Advisory Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Keating Financial Advisory Services held 4,601 shares of Pfizer worth $111K as of Q2 2026.
- Keating Financial Advisory Services bought 695 Pfizer shares in Q2 2026, an estimated $18.2K.
- Pfizer made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #464 holding.
- Keating Financial Advisory Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.